List of Bioinformatics Companies in Finland - 4

CardioSignal is a health technology company developing groundbreaking solutions for early detection of heart diseases. We are based in Turku, Finland and Palo Alto, CA, United States. The CardioSignal mobile application is a CE-marked class IIa medical device for the detection of atrial fibrillation, available in over 10 countries. The technology we are developing enables a digital cardiac biomarker for other major heart diseases as well. CardioSignal is a brand and a product by Precordior. Originally an academic spinoff, the company’s patented motion sensor technology is built on a decade of research and algorithm development. Our purpose We are supporting healthcare in battling the #1 killer of people in the world. With heart disease numbers only rising, we are facing a health and economic problem described as an epidemic by researchers and physicians around the world. Early identification and treatment of heart disease, such as atrial fibrillation, would help prevent strokes and heart attacks and improve outcomes for individuals and society.

Euformatics provides expert computational services at the intersection of life sciences and software. Our mission is to bridge the gap between practicing life scientists and creators of new data analysis and modeling methods, accelerating the transition to precision medicine. Our focus is in adapting cutting-edge research in computational methods and putting them to practice. Our customers are biotech companies and healthcare providers in Finland and abroad.

Genevia Technologies is a Finnish CRO specialized in delivering diverse bioinformatics solutions. The company was founded in 2011 as a spin-off enterprise by a group of computational systems biology researchers from Tampere University of Technology, in Tampere, Finland. Over a course of 15 years, our team has built up an extensive experience in analyzing and integrating various microarray, next-generation sequencing and proteomics data. We have also been developing and applying systems biological and mathematical modeling techniques on a wide range of applications from bacterial metabolomics to genomics of human cancers. Our mission is to facilitate the use of high-throughput genetic measurements and biological big data in life science companies and research institutions. We provide general genomics and bioinformatics consultation, support in experimental design, acquisition of cost-effective experiments, analysis and integration of data, and design of custom data analysis and visualization pipelines that organizations can use to analyze their data independently. You can find more information about our company, services and customers on our website at http://www.geneviatechnologies.com

Nexstim is a Finnish, globally operating medical technology company. Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain. In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on Nasdaq First North Growth Market Finland.